会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 9. 发明授权
    • Preparation of calcium L-ascorbate 2-phosphate
    • L-抗坏血酸钙2-磷酸钙的制备
    • US5420302A
    • 1995-05-30
    • US102745
    • 1993-08-06
    • Klaus KaiserFriedhelm BalkenhohlJoachim Paust
    • Klaus KaiserFriedhelm BalkenhohlJoachim Paust
    • C07F9/655C07F9/06
    • C07F9/65515
    • A process for isolating the calcium salt of ascorbyl 2-monophosphate from aqueous alkaline reaction mixtures as are obtained on reaction of ascorbic acid with a molar excess of phosphorus oxychloride in the presence of a tertiary amine while maintaining a pH of from 12 to 13 during the reaction by means of an aqueous alkali metal hydroxide solution, which comprisesa) starting from a reaction mixture which has been obtained by reacting ascorbic acid with phosphorus oxychloride in the presence of pyridine while maintaining a pH of from 12 to 13 by means of an aqueous potassium hydroxide solution,b) precipitating, as potassium magnesium phosphate, the phosphate ions which have been formed in this reaction by means of magnesium chloride in amounts of about 1 mol per mol of phosphate ions,c) removing the potassium magnesium phosphate,d) distilling the remaining aqueous solution to remove the pyridine together with part of the water,e) reacting the resulting aqueous solution with calcium chloride andf) isolating the calcium salt of ascorbyl 2-monophosphate which crystallizes thereby, or first distilling the pyridine-water mixture according to step (d) from the reaction mixture obtained in step (a) and thereafter carrying out steps (b), (c), (e) and (f).
    • 在碱性反应混合物水溶液中分离抗坏血酸2-单磷酸钙的方法,该方法是在叔胺存在下使抗坏血酸与摩尔过量的三氯氧化磷反应得到的,同时保持pH为12至13 通过碱金属氢氧化物水溶液进行反应,其包括a)从吡啶存在下使抗坏血酸与三氯氧磷反应获得的反应混合物开始,同时通过水溶液保持pH为12至13 氢氧化钾溶液,b)以磷酸镁钾的形式沉淀在该反应中通过氯化镁形成的磷酸根离子,其量为每摩尔磷酸根离子约1摩尔,c)除去磷酸镁钾,d) 蒸馏剩余的水溶液以与一部分水一起除去吡啶,e)使所得水溶液与calciu反应 m),和f)分离由此结晶的2-抗坏血酸的钙盐,或者首先从步骤(a)获得的反应混合物中蒸馏出根据步骤(d)的吡啶 - 水混合物,然后进行步骤(b) ,(c),(e)和(f)。
    • 10. 发明授权
    • Method for producing esters of triazolopyrimidine derivatives free of enantiomers using vinylesters with lipase
    • 使用具有脂肪酶的乙烯基酯制备不含对映异构体的三唑并嘧啶衍生物的酯的方法
    • US06234811B1
    • 2001-05-22
    • US09319875
    • 1999-06-14
    • Friedhelm BalkenhohlStefan KoserNicholas John Holman
    • Friedhelm BalkenhohlStefan KoserNicholas John Holman
    • C12P1718
    • C12P41/004C12P17/182
    • A process for preparing enantiomerically pure esters of the formula I (Ia and Ib) where the substituents have the following meanings: R1 hydrogen or substituted or unsubstituted C1-C6-alkyl, C1-C6-alkoxy or Cl-C6-alkanoyl, R2 and R3 independently of one another hydrogen or substituted or unsubstituted C1-C6-alkyl, C1-C6-alkoxy, C1-C6-alkanoyl, C1-C6-alkylthio, C1-C6-alkylsulfinyl or C1-C6-alkylsulfonyl, R4 and R5 R4≠R5 and independently of one another hydrogen or substituted or unsubstituted C1-C6-alkyl or R4 and R5 form together with the carbon atoms to which they are bonded a substituted or unsubstituted C3-C6-cycloalkylidene, R6 substituted or unsubstituted aryl, C1-C20-alkyl, C3-C20-alkenyl, C3-C20-alkynyl, C1-C20-alkoxy-C1-C20-alkyl comprises converting racemic compounds of the formula II, where the substituents R1 to R5 have the abovementioned meanings, with a lipase or esterase in the presence of vinyl esters of the formula III, where R6 has the abovementioned meaning, and R7 is hydrogen or methyl, into compounds of the formula I.
    • 制备式I(Ia和Ib)的对映异构体纯的酯的方法,其中取代基具有以下含义:R 1氢或取代或未取代的C 1 -C 6 - 烷基,C 1 -C 6 - 烷氧基或C 1 -C 6 - 烷酰基,R 2和R 3独立地 的另一个氢或取代或未取代的C 1 -C 6 - 烷基,C 1 -C 6 - 烷氧基,C 1 -C 6 - 烷酰基,C 1 -C 6 - 烷硫基,C 1 -C 6烷基亚磺酰基或C 1 -C 6烷基磺酰基,R 4和R 5 R 4 并且彼此独立地是氢或取代或未取代的C 1 -C 6 - 烷基或R 4和R 5与它们所连接的碳原子一起形成取代或未取代的C 3 -C 6 - 亚环烷基,R 6取代或未取代的芳基,C 1 -C 20 - 烷基 C 3 -C 20烯基,C 3 -C 20炔基,C 1 -C 20烷氧基-C 1 -C 20烷基,其中取代基R 1至R 5具有上述含义的式II外消旋化合物与脂肪酶或酯酶 存在式III的乙烯基酯,其中R 6具有上述含义,并且R 7是氢 或甲基转化成式I的化合物。